After a painful breakup, 28-year-old Mikaela Wild, a social media content strategist in Los Angeles, sat on her couch, phone in hand. Wary of bombarding a friend and without a therapist to consult, she opened ChatGPT and plugged in a summary of her three-year relationship, concluding with the question, “Why didn’t things work out?”

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

Australian scientists have developed a groundbreaking approach that harnesses artificial biological intelligence to rapidly evolve molecules with improved functions directly within mammal cells. This system, named PROTEUS, short for PROTein Evolution Using ...

An AI hallucination occurs when a model confidently produces an incorrect output — a faulty conclusion based on inaccurate or misinterpreted data patterns. The machine doesn’t “know” it’s wrong. It simply detects a pattern, extrapolates from it and moves on, often without signaling that its reasoning may be flawed.

From streamlining clinical trials to identifying new drug candidates in record time, artificial intelligence is transforming the pharmaceutical industry. Coming up tonight, News Channel 3 will beak down how this technology works,

Artificial intelligence (AI) promises to be one of the most transformative technologies in human history, and certain Wall Street analysts think Palantir Technologies ( PLTR 3.58%) and AppLovin ( APP 3.46%) are particularly well positioned to benefit.

AI is dumbing us down. But paradoxically, when used judiciously in combination with human thought, the very same tool could be a doorway to increased wisdom.

NVIDIA CEO and co-founder Jensen Huang commends President Donald Trump’s A.I. agenda and outlines what the country's job future will look like on 'Special Report.'